Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV

Saußele, Susanne; Lauseker, Michael; Gratwohl, Aloïs; W. Beelen, Dietrich; Bunjes, Donald; Schwerdtfeger, Rainer; Kolb, Hans‐Jochem; D. Ho, Anthony; Falge, Christiane; Holler, Ernst; Schlimok, Günter; R. Zander, Axel; Arnold, Renate; Kanz, Lothar; Dengler, Robert; Haferlach, Claudia; Schlegelberger, Brigitte; Pfirrmann, Markus; C. Müller, Martin; Schnittger, Susanne; Leitner, Armin; Pletsch, Nadine; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger; the German CML Study Group, for

doi:10.1182/blood-2009-08-237115

Public

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV

Published in Blood • Nov 18, 2009

Authors:

Susanne Saußele

Michael Lauseker

Aloïs Gratwohl

Abstract

The role of allogeneic stem cell transplantation in chronic myeloid leukemia is being reevaluated. Whereas drug treatment has been shown to be superior in first-line treatment, data on allogeneic hematopoietic stem cell transplantation (allo SCT) as second-line therapy after imatinib failure are sca...

Subject

Medicine

Transplantation

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!